Clinical trial
Experimental Ebola Vaccine Trial
NCT00072605 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00072605 |
|---|---|
| Title | Experimental Ebola Vaccine Trial |
| Official title | VRC 204 A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP, in Adult Volunteers |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hemorrhagic Fever, Ebola, Healthy |
| Intervention type | Drug |
| Interventions | VRC-EBODNA012-00-VP |
| Enrollment | 27 |
| Start date | Oct 30, 2003 |
| Completion | Aug 22, 2007 |
| First posted | Nov 5, 2003 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: